Success requires orchestrating an end-to-end experience that connects manufacturing, logistics, clinical sites, payers, and patients seamlessly. The companies that treat this orchestration as a strategic competency, rather than just operational logistics, will be best positioned to scale. The post Scaling Radioligand Therapy: 3 Essential Strategies From Inside The Ecosystem appeared first on MedCity News.
[Sponsored] Sign up today and and join us on May 8th where we’ll explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies. The post Webinar: How Fintech Can Accelerate Growth for Early-Stage Life Science Companies appeared first on MedCity News.
Beyond the branded products currently sold by Mallinckrodt and Endo, the companies say the combined business will also have a strong foundation in rare and orphan diseases. Generic medicines will be spun out as a separate company. The post Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal appeared first…
Roche’s Tecentriq Hybreza is a subcutaneously injectable formulation of the cancer drug Tecentriq while Ocrevus Zunovo is an injectable version of multiple sclerosis drug Ocrevus. Each is administered in minutes compared to an hour or more for infused therapies. The post Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs appeared first…
These two promising changes in national healthcare policy could transform access to care for millions of Americans. The post A Moment of Opportunity to Expand Healthcare Access in the US appeared first on MedCity News.
[Sponsored] A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices. The post Navina’s AI Copilot Eases the Value-Based Burden, Study Shows appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
If you dare, feast your eyes on this year’s winners of KFF Health News’ sixth annual Halloween Haiku contest. We received more than four dozen spooky submissions but only a few bubbled to the top of the cauldron. Here’s the winner and the top runners-up, illustrated by Oona Zenda. The judges’ favorites were inspired by…
Addressing the obesity-cancer connection begins with awareness. The more we understand how excess weight influences cancer risk, the better equipped we are to intervene early, tailor treatment, and support long-term health. The post Obesity, Cancer, and the New Frontier of Treatment appeared first on MedCity News.
One of the most important things providers can do on the journey toward consumer-driven care is to check their paternalism at the door, said Nworah Ayogu, head of healthcare impact at Thrive Capital. The post These 3 Mindset Shifts Will Help Providers Deliver Consumer-Driven Care, Investor Says appeared first on MedCity News.